From: Prevalence of pituitary disorders associated with aneurysmal subarachnoid hemorrhage
 | Hypopituitarism | GH | ACTH | TSH | Gonadal | ADH |
---|---|---|---|---|---|---|
Short term | Â | Â | Â | Â | Â | Â |
All studies | 53.4% (20.5 to 84.7) | 30.4% (11.5 to 53.2) | 13.2% (4.4 to 25.1) | 49.2% (0.1 to 17.7) | 26.1% (8.8 to 48.0) | 6.3% (2.7 to 11.0) |
n (patients) | 5 (235) | 8 (346) | 13 (537) | 7 (327) | 8 (351) | 3 (481) |
I 2 | 96.0% | 93.5% | 90.2% | 89.1% | 93.0% | 61.1% |
Studies of low risk of bias (patients) | 2(56) | - | - | 2(56) | 1(26) | - |
Mid-term | Â | Â | Â | Â | Â | Â |
All studies | 36.5% (13.6 to 62.8) | 7.3% (0.6 to 18.3) | 8.9% (1.3 to 21.0) | 8.8% (2.4 to 18.0) | 3.9% (0.0 to 11.9) | 3.7% (0.6 to 13.5) |
n (patients) | 4 (109) | 6 (158) | 7 (208) | 5 (176) | 6 (178) | 2(56) |
I 2 | 85.7% | 70.9% | 79.4% | 59.4% | 66.8% | 29.0% |
Studies with low risk of bias (patients) | 1(40) | - | - | 1(40) | - | - |
Long-term | Â | Â | Â | Â | Â | Â |
All studies | 34.2% (18.7 to 51.4) | 17.1% (9.4 to 26.4) | 11.2% (4.8 to 19.4) | 2.3% (0.4 to 5.3) | 3.2% (0.7 to 6.8) | 0% (0 to 1.5) |
n (patients) | 12 (486) | 13 (531) | 13 (531) | 12 (486) | 13(351) | 3 (142) |
I 2 | 92.5% | 82.9% | 82.9% | 49.0% | 62.9% | 0% |
Studies with low risk of bias (patients) | 2(40) | 2(40) | 2(40) | 2(40) | 1(10) | - |